Oral octreotide ‘feasible’ alternative acromegaly treatment: study
The capsules have been found non-inferior to the standard injectable therapy, researchers say
Patients with acromegaly may do just as well on oral octreotide treatment as injectable somatostatin receptor ligands, a US-led study shows.
Although the oral formulation of the drug is yet to be approved in Australia, the findings suggest it could be a “favourable alternative” treatment for the growth hormone disorder.
